Back to today’s briefing

Story perspectives

New Cryoablation Technique Halts Prostate Cancer Recurrence in 89%

3/21/2025

40 3

Summary

Story summary

A groundbreaking five-year study by NYU researchers revealed that primary partial-gland cryoablation successfully halted cancer recurrence in 89% of 91 men with intermediate-risk prostate cancer. This innovative approach not only maintained urinary and sexual function but also highlighted the critical need for rigorous follow-up, offering hope beyond traditional whole-gland treatments.

1 of 1

Story summary

A groundbreaking five-year study by NYU researchers revealed that primary partial-gland cryoablation successfully halted cancer recurrence in 89% of 91 men with intermediate-risk prostate cancer. This innovative approach not only maintained urinary and sexual function but also highlighted the critical need for rigorous follow-up, offering hope beyond traditional whole-gland treatments.